Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Iscience
|
January 1, 2026
Advances in the clinical application of bispecific antibodies in cancer therapy
Shiqi Zhou, Feng Li, Mengke Niu, et al.
Frontiers in Immunology
|
January 5, 2023
TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Biomarker Research
|
July 8, 2021
Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study
Ming Yi, Tianye Li, Mengke Niu, et al.
Frontiers in Immunology
|
February 26, 2024
CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang, et al.
Anti-Cancer Drugs
|
August 13, 2021
Anlotinib is effective in the treatment of advanced pancreatic cancer: a case report
Shuyi Li, Mengke Niu, Wenying Deng, et al.
Frontiers in Immunology
|
March 29, 2024
STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance
Tianye Li, Weijiang Zhang, Mengke Niu, et al.
Frontiers in Immunology
|
July 31, 2023
Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy
Tianye Li, Xinrun Wang, Mengke Niu, et al.
Cancer Management and Research
|
December 17, 2021
Efficacy of Chemotherapy versus Transcatheter Arterial Chemoembolization in Patients with Advanced Primary Hepatic Neuroendocrine Carcinoma and an Analysis of the Prognostic Factors: A Retrospective Study
Shuyi Li, Mengke Niu, Wenying Deng, et al.
Signal Transduction and Targeted Therapy
|
July 21, 2024
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Biomarker Research
|
December 14, 2023
S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1
Xiaojun Zhang, Mengke Niu, Tianye Li, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Iscience
|
January 1, 2026
Advances in the clinical application of bispecific antibodies in cancer therapy
Shiqi Zhou, Feng Li, Mengke Niu, et al.
Frontiers in Immunology
|
January 5, 2023
TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Biomarker Research
|
July 8, 2021
Epidemiological trends of women's cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study
Ming Yi, Tianye Li, Mengke Niu, et al.
Frontiers in Immunology
|
February 26, 2024
CAR-NK cells for cancer immunotherapy: recent advances and future directions
Tianye Li, Mengke Niu, Weijiang Zhang, et al.
Anti-Cancer Drugs
|
August 13, 2021
Anlotinib is effective in the treatment of advanced pancreatic cancer: a case report
Shuyi Li, Mengke Niu, Wenying Deng, et al.
Frontiers in Immunology
|
March 29, 2024
STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance
Tianye Li, Weijiang Zhang, Mengke Niu, et al.
Frontiers in Immunology
|
July 31, 2023
Bispecific antibody targeting TGF-β and PD-L1 for synergistic cancer immunotherapy
Tianye Li, Xinrun Wang, Mengke Niu, et al.
Cancer Management and Research
|
December 17, 2021
Efficacy of Chemotherapy versus Transcatheter Arterial Chemoembolization in Patients with Advanced Primary Hepatic Neuroendocrine Carcinoma and an Analysis of the Prognostic Factors: A Retrospective Study
Shuyi Li, Mengke Niu, Wenying Deng, et al.
Signal Transduction and Targeted Therapy
|
July 21, 2024
Targeting cytokine and chemokine signaling pathways for cancer therapy
Ming Yi, Tianye Li, Mengke Niu, et al.
Biomarker Research
|
December 14, 2023
S100A8/A9 as a risk factor for breast cancer negatively regulated by DACH1
Xiaojun Zhang, Mengke Niu, Tianye Li, et al.
Page
of 4